LOS ANGELES, March 25, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced that it will exhibit its CE Mark approved, non-invasive Monarch™ eTNS™ System for the adjunctive treatment of epilepsy and depression, at the 4th...